#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

žena_vozík

Teriflunomide "under the microscope" or what it's like to live with MS in the North

12. 1. 2023 Source: Multiple Sclerosis

The Teri-LIFE study examined teriflunomide very comprehensively. How does it manage to affect the quality of life of patients with multiple sclerosis (MS) according to data from real clinical practice in the Nordic countries? What is adherence to this therapy like? And what are its health-economic consequences? We briefly summarize the answers to these questions.

kardiologie výzkum

Cardiovascular Interventions with Continued Therapy with Dabigatran − Insights from the GLORIA-AF Study

An analysis using data from an international registry of patients with newly diagnosed atrial…
12. 1. 2023 Source: Anticoagulant Treatment
magnetická_rezonance

Smouldering Multiple Sclerosis: How Can MRI Help in Its Identification?

With the changing understanding of the etiopathogenesis of multiple sclerosis, several new…
4. 1. 2023 Source: Multiple Sclerosis
léky_tablety

Teriflunomide vs. Dimethyl Fumarate: Does Their Classification into Different Treatment Lines Have Merit?

Teriflunomide is one of the first-choice medications in the treatment of multiple sclerosis (MS)…
4. 1. 2023 Source: Multiple Sclerosis
nemocnice příjem čekárna

Prevalence of Heart Failure and Its Subtypes in the Population of Developed Countries

In developed countries, heart failure occurs in approximately 2% of the population, with an annual…
2. 1. 2023 Source: Heart Failure
dyslipidémie

Inclisiran − a new addition to the arsenal of dyslipidemia treatment

At the XXIX Congress of the Czech Society of Internal Medicine ČLS JEP, held November 6−9, 2022 in…
23. 12. 2022 Source: Chronic Heart Failure and Lipidology
LDL cholesterol

Use of Inclisiran in a Patient in Secondary Cardiovascular Prevention

Lowering LDL cholesterol (LDL-c) is one of the primary goals for reducing cardiovascular (CV) risk…
23. 12. 2022 Source: Chronic Heart Failure and Lipidology
fokální záchvaty

Cenobamate − A Case Study from Slovak Real Practice

Cenobamate is indicated for adjunctive therapy of focal seizures with or without secondary…
23. 12. 2022 Source: Epilepsy
karcinom plic_lékař

Brigatinib in the Therapy of Pretreated Patients with Advanced ALK-Positive NSCLC

A French study analyzed clinical data of pretreated ALK-positive patients with advanced non-small…
22. 12. 2022 Source: Non-Small Cell Lung Cancer
mnohočetný myelom

Addition of ixazomib to lenalidomide and dexamethasone in multiple myeloma − Data from real-world Czech practice

A group of Czech and Slovak experts led by Associate Professor Jiří Minařík from the…
22. 12. 2022 Source: Hematologic Malignancies
1 45 46 47 48 49 161
Filter by speciality
Remove filters

Conferences

News from the world of medicine

16. 1.
Léčba rány
XIII. Celostátní kongres České společnosti pro léčbu rány s mezinárodní účastí

All conferences
Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#